Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Storb

Showing results (671-680 of 899) with videos related to

Pageof 90
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1974
Effect of prior blood transfusions on marrow grafts: abrogation of sensitization by procarbazine and antithymocyte serumR Storb, G L Floersheim, P L Weiden, et al.
Transplantation Proceedings|February 1, 1987
Marrow transplantation for leukemia and aplastic anemia: two controlled trials of a combination of methotrexate and cyclosporine v cyclosporine alone or methotrexate alone for prophylaxis of acute graft-v-host diseaseR Storb, H J Deeg, J Whitehead, et al.
Blood|October 1, 1993
Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factorC H Weaver, C D Buckner, K Longin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 29, 2000
Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host diseaseF Carnevale-Schianca, P Martin, K Sullivan, et al.
Bone Marrow Transplantation|April 1, 1996
Busulfan, cyclophosphamide and fractionated total body irradiation for autologous or syngeneic marrow transplantation for acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levelsT Demirer, C D Buckner, F R Appelbaum, et al.
Blood|August 15, 1991
Graft-versus-host disease prophylaxis with methotrexate/cyclosporine in children with severe aplastic anemia treated with cyclophosphamide and HLA-identical marrow graftsR Storb, J E Sanders, M Pepe, et al.
American Journal of Hematology|January 1, 1978
Relapse following marrow transplantation for acute leukemiaD T Harrison, N Flournoy, R Ramberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1989
Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapyJ Mortimer, M A Blinder, S Schulman, et al.
The New England Journal of Medicine|September 21, 1989
Secondary cancers after bone marrow transplantation for leukemia or aplastic anemiaR P Witherspoon, L D Fisher, G Schoch, et al.
The American Journal of Pathology|June 1, 1978
Chronic cutaneous graft-versus-host disease in manH M Shulman, G E Sale, K G Lerner, et al.
Pageof 90

Showing results (671-680 of 899) with videos related to

Sort By:
Pageof 90
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1974
Effect of prior blood transfusions on marrow grafts: abrogation of sensitization by procarbazine and antithymocyte serumR Storb, G L Floersheim, P L Weiden, et al.
Transplantation Proceedings|February 1, 1987
Marrow transplantation for leukemia and aplastic anemia: two controlled trials of a combination of methotrexate and cyclosporine v cyclosporine alone or methotrexate alone for prophylaxis of acute graft-v-host diseaseR Storb, H J Deeg, J Whitehead, et al.
Blood|October 1, 1993
Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factorC H Weaver, C D Buckner, K Longin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 29, 2000
Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host diseaseF Carnevale-Schianca, P Martin, K Sullivan, et al.
Bone Marrow Transplantation|April 1, 1996
Busulfan, cyclophosphamide and fractionated total body irradiation for autologous or syngeneic marrow transplantation for acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levelsT Demirer, C D Buckner, F R Appelbaum, et al.
Blood|August 15, 1991
Graft-versus-host disease prophylaxis with methotrexate/cyclosporine in children with severe aplastic anemia treated with cyclophosphamide and HLA-identical marrow graftsR Storb, J E Sanders, M Pepe, et al.
American Journal of Hematology|January 1, 1978
Relapse following marrow transplantation for acute leukemiaD T Harrison, N Flournoy, R Ramberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1989
Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapyJ Mortimer, M A Blinder, S Schulman, et al.
The New England Journal of Medicine|September 21, 1989
Secondary cancers after bone marrow transplantation for leukemia or aplastic anemiaR P Witherspoon, L D Fisher, G Schoch, et al.
The American Journal of Pathology|June 1, 1978
Chronic cutaneous graft-versus-host disease in manH M Shulman, G E Sale, K G Lerner, et al.
Pageof 90